DEZHAN HEALTHCARE(SZ:000813) Sou Hu Cai Jing·2025-07-30 07:33Core Insights - Dezheng Health's stock reached a closing price of 4.41 yuan on July 30, with a limit-up increase of 9.98% [1] - The stock's limit-up was attributed to several factors, including improved corporate governance, completion of a share buyback plan, resolution of shareholder equity auction uncertainties, and a significant increase in R&D investment [1] Summary by Category Stock Performance - On July 30, Dezheng Health's stock closed at 4.41 yuan, marking a 9.98% increase [2] - The stock hit its limit-up at 14:48 and did not open again, with a closing order amount of 34.54 million yuan, accounting for 0.36% of its market capitalization [1] Financial Metrics - The net inflow of main funds was 151 million yuan, representing 18.36% of the total trading volume [2] - Retail investors experienced a net outflow of 80.95 million yuan, which is 9.87% of the total trading volume [2] Company Developments - The company has optimized its governance structure by revising board meeting rules to enhance the authority of independent directors [1] - A share buyback plan was completed, with a total of 2.85% of shares repurchased, reflecting management's confidence in future growth [1] - The resolution of shareholder equity judicial auction has reduced market uncertainties [1] - R&D investment increased by 53% year-on-year, focusing on innovative drugs for cardiovascular and anti-tumor treatments, supported by academic partnerships [1]